Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma

Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma

Immunotherapy is increasingly used in the treatment of glioblastoma (GBM), with immune checkpoint therapy gaining in popularity given favorable outcomes achieved for other tumors. However, immune-mediated (IM)-pseudoprogression is common, remains poorly characterized, and renders conventional imagin...

Full description

Bibliographic Details
Main Authors: Shadi Daghighi, Naeim Bahrami, William J. Tom, Nicholas Coley, Tyler M. Seibert, Jona A. Hattangadi-Gluth, David E. Piccioni, Anders M. Dale, Nikdokht Farid, Carrie R. McDonald
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Oncology
Subjects:
brain tumors
restriction spectrum imaging
immunotherapy
pseudoprogression
diffusion imaging
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00024/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00024/full

Similar Items